Company / Operating Margin
Coherus Oncology, Inc. Operating Margin History
FY2014-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-14918.8%
FY2017
5-year range
-14918.8% / -207.9%
FY2014-FY2017
Trend
-7074.6%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -7075% YoY in FY2017, a notable deviation from the 3-year average annual change of -2318%.
Based on SEC 10-K filings.
-14918.8% in FY2017 with a 3-year CAGR of -12890.4%.
Declined from -1308.4% to -14918.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -12890.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, operating margin decreased 7074.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -14918.8% | -7074.6% |
| FY2016 | -207.9% | +84.1% |
| FY2015 | -1308.4% | +35.5% |
| FY2014 | -2028.3% | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026